Advertisement
Screener

Lite Strategy, Inc. (LITS) Gain (Loss) on Derivative Instruments, Net, Pretax

2.8 / 5 stars · 68/120 Roast Me

Lite Strategy, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax

Lite Strategy, Inc. (LITS) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$508.00 thousand for the 160-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2014-05-08

  • Lite Strategy, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2011 was -$508.00K.
Period endGain (Loss) on Derivative Instruments, Net, Pretax 12 monthGain (Loss) on Derivative Instruments, Net, Pretax 130 monthGain (Loss) on Derivative Instruments, Net, Pretax 133 monthGain (Loss) on Derivative Instruments, Net, Pretax 136 monthGain (Loss) on Derivative Instruments, Net, Pretax 139 monthGain (Loss) on Derivative Instruments, Net, Pretax 142 monthGain (Loss) on Derivative Instruments, Net, Pretax 145 monthGain (Loss) on Derivative Instruments, Net, Pretax 148 monthGain (Loss) on Derivative Instruments, Net, Pretax 151 monthGain (Loss) on Derivative Instruments, Net, Pretax 154 monthGain (Loss) on Derivative Instruments, Net, Pretax 157 monthGain (Loss) on Derivative Instruments, Net, Pretax 160 month
2014-03-31-$508.00K
10-Q · filed 2014-05-08
2013-12-31-$508.00K
10-Q · filed 2014-02-11
2013-09-30-$508.00K
10-Q · filed 2013-11-08
2013-06-30-$508.00K
10-K · filed 2013-09-18
2013-03-31-$508.00K
10-Q · filed 2013-05-09
2012-12-31-$508.00K
10-Q · filed 2013-02-12
2012-09-30-$508.00K
10-Q · filed 2012-11-13
2012-06-30-$508.00K
10-K · filed 2012-09-18
2012-03-31-$508.00K
10-Q · filed 2012-05-15
2011-12-31-$508.00K
10-Q · filed 2012-02-09
2011-09-30-$508.00K
10-Q · filed 2011-11-14
2011-06-30-$508.00K
10-K · filed 2012-09-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38